Estimated Savings From Extending Prescription Drug Inflationary Rebates To All Commercial Plans.
Sign Up to like & getrecommendations! Published in 2025 at "Health affairs"
DOI: 10.1377/hlthaff.2024.00724
Abstract: The inflationary rebate provisions of the Inflation Reduction Act (IRA) of 2022 require pharmaceutical manufacturers to pay money back to Medicare if they raise prices faster than the rate of inflation. Opportunities now exist for… read more here.
Keywords: rebates commercial; extending prescription; inflationary rebates; estimated savings ... See more keywords